Loading data for DXR — first visit, this takes a few seconds.
Daxor Corporation (DXR)
NasdaqCM: DXR
· 即時價格 · USD
10.27
-0.28 (-2.65%)
收盤價： Sep 04, 2026, 8:00 PM
股價、關鍵數字和最新消息，都在這一頁。
Daxor Corporation（DXR）股價、分析與資料
無可用資料
| 買價 | 11.5 |
| 市值 | 60M |
| 營收 (ttm) | 31.4K |
| 淨利（ttm） | 6.23M |
| 0.26 | |
| 1.69 | |
| 6.08 | |
| n/a | |
| P/B (ttm) | 1.13 |
| P/S (ttm) | 1911.94 |
| 財報日期 | May 13, 2004 |
| 賣價 | 10.69 |
| 成交量 | 6,788 |
| 20 日平均成交量 | 3,936 |
| 開盤價 | 10.24 |
| 前收盤價 | 10.55 |
| 當日區間 | 10.15 - 10.50 |
| 52 週範圍 | 8.56 - 14.76 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | Jan 5, 2018 |
關於 DXR
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartere...
完整的公司簡介財報驚奇
Daxor 已於 Aug 26, 2019 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 0.06 超出預期 0.04, 年增 -79.31% 下滑.
